Informations sur le produit
Nom :
Fosamprenavir calcium
Synonymes :
- [u'(3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)carbamic acid C-(tetrahydro-3-furanyl) ester', u'fos-amprenavir', u'fosamprenavir', u'GW 433908', u'GW 433908G', u'GW 908', u'GW-433908', u'GW-433908G', u'GW-908', u'GW433908', u'GW433908G', u'GW908 cpd', u'Lexiva', u'VX 175', u'VX-175', u'VX175 cpd', u'226700-81-8', u'Lexiva', u'Fosamprenavir (Calcium Salt)', u'Amprenavir phosphate calcium', u'UNII-ID1GU2627N', u'GW433908G', u'Fosamprenavir calcium [USAN]', u'ID1GU2627N', u'Lexiva (TN)', u'((3S)Oxolan-3-yloxy)-N-((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-benzyl-2-(phosphonooxy)propyl)carboxamide calcium salt', u'Fosamprenavir calcium (USAN)', u'(3S)-Tetrahydro-3-furyl ((alphaS)-alpha-((1R)-1-hydroxy-2-(N(sup 1)-isobutylsulfanilamido)ethyl)phenethyl)carbamate, calcium phosphate (ester) (1:1)', u'Calcium [(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-1-phenyl-3-phosphonatooxy-butan-2-yl]carbamate', u'Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)-, C-((3S)-tetrahydro-3-furanyl) ester, calcium salt', u'Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)-, C-((3S)-tetrahydro-3-furanyl) ester, calcium salt (1:1)', u'GW-433908G', u'Telzir (TN)', u'AC1L2ZCL', u'NCGC00168771-01', u'C25H34CaN3O9PS', u'DSSTox_CID_26777', u'DSSTox_RID_81896', u'DSSTox_GSID_46777', u'MLS006012033', u'SCHEMBL1649283', u'CHEMBL1200734', u'DTXSID0046777', u'PMDQGYMGQKTCSX-HQROKSDRSA-L', u'Tox21_112632', u'AKOS015950832', u'CS-1411', u'GW 433908G', u'Fosamprenavir calcium, >=98% (HPLC)', u'AN-16772', u'HY-17431', u'SMR004703563', u'AB1004608', u'AX8246818', u'GW-433908', u'LS-186584', u'ST2419393', u'CAS-226700-81-8', u'FT-0668861', u'Z4451', u'D03835', u'calcium [(1R,2S)-1-[[(4-aminophenyl)sulfonyl-isobutyl-amino]methyl]-3-phenyl-2-[[(3S)-tetrahydrofuran-3-yl]oxycarbonylamino]propyl] phosphate', u'calcium [(2R,3S)-1-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-[[(3S)-oxolan-3-yl]oxycarbonylamino]-4-phenylbutan-2-yl] phosphate', u'Telzir', u'Fosamprenavircalcium', u'Fosamprenavir Calcium Salt', u'C25H36N3O9PS.Ca', u'226700-81-8 (calcium)', u'CID131535', u'VX-175', u'C25-H36-N3-O9-P-S.Ca']
- Calcium [(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-1-phenyl-3-phosphonatooxy-butan-2-yl]carbamate
- Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-1-(phenylmethyl)-2-(phosphonooxy)propyl]-, C-[(3S)-tetrahydro-3-furanyl] ester, calcium salt (1:1)
- Fosamprenavir calcium salt
- Gw 433908G
- Lexiva
- Telzir
- calcium (2R,3S)-1-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-4-phenyl-3-({[(3S)-tetrahydrofuran-3-yloxy]carbonyl}amino)butan-2-yl phosphate
- carbamic acid, N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-1-(phenylmethyl)-2-(phosphonooxy)propyl]-, (3S)-tetrahydro-3-furanyl ester, calcium salt (1:1)
CAS :
Marque:
Indagoo
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
623.6689
Formule :
C25H34CaN3O9PS
Degré de pureté :
98%
Couleur/Forme :
Solid
InChI :
InChI=1S/C25H36N3O9PS.Ca/c1-18(2)15-28(39(33,34)22-10-8-20(26)9-11-22)16-24(37-38(30,31)32)23(14-19-6-4-3-5-7-19)27-25(29)36-21-12-13-35-17-21;/h3-11,18,21,23-24H,12-17,26H2,1-2H3,(H,27,29)(H2,30,31,32);/q;+2/p-2/t21-,23-,24+;/m0./s1
Code InChI :
PMDQGYMGQKTCSX-HQROKSDRSA-L
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
